BlossomHill Therapeutics, Inc. (BLSM)
NASDAQ: BLSM · Real-Time Price · USD
19.38
+0.39 (2.05%)
Sep 2, 2026, 4:00 PM EDT - Market closed
BlossomHill Therapeutics Market Cap
BlossomHill Therapeutics has a market cap or net worth of $593.87 million as of September 2, 2026.
Market Cap
593.87M
Enterprise Value
500.89M
1-Year Change
n/a
Ranking
Category
Stock Price
$19.38
ChartMarket Cap Chart
Since the IPO on August 7, 2026, BlossomHill Therapeutics's market cap has increased from $465.30M to $593.87M, an increase of 27.63%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 2, 2026 | 593.87M | 2.05% |
| Sep 1, 2026 | 581.92M | 3.77% |
| Aug 31, 2026 | 560.78M | -6.44% |
| Aug 28, 2026 | 599.39M | -1.21% |
| Aug 27, 2026 | 606.74M | 7.26% |
| Aug 26, 2026 | 565.68M | 0.22% |
| Aug 25, 2026 | 564.46M | 14.91% |
| Aug 24, 2026 | 491.22M | -2.14% |
| Aug 21, 2026 | 501.94M | 3.67% |
| Aug 20, 2026 | 484.17M | -2.29% |
| Aug 19, 2026 | 495.51M | 0.43% |
| Aug 18, 2026 | 493.36M | -1.71% |
| Aug 17, 2026 | 501.94M | 1.24% |
| Aug 14, 2026 | 495.81M | -1.04% |
| Aug 13, 2026 | 501.02M | 0.68% |
| Aug 12, 2026 | 497.65M | -1.69% |
| Aug 11, 2026 | 506.23M | 3.31% |
| Aug 10, 2026 | 489.99M | 5.31% |
| Aug 7, 2026 | 465.30M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Autolus Therapeutics | 617.50M |
| Tectonic Therapeutic | 616.10M |
| Arvinas | 602.86M |
| Altimmune | 599.11M |
| Valneva SE | 596.47M |
| Capricor Therapeutics | 584.88M |
| ARS Pharmaceuticals | 578.78M |
| Eikon Therapeutics | 578.48M |